{"id":265,"date":"2015-09-01T15:00:28","date_gmt":"2015-09-01T06:00:28","guid":{"rendered":"https:\/\/glocalink.com\/?p=265"},"modified":"2018-02-21T23:21:51","modified_gmt":"2018-02-21T14:21:51","slug":"1tp3-te31-tp3t831tp3-tbc-18","status":"publish","type":"post","link":"https:\/\/glocalink.com\/en\/2015\/09\/01\/265\/","title":{"rendered":"Capital increase through third-party allotment to JT - Accelerate investment and development of technology ventures in Japan and overseas"},"content":{"rendered":"

(Headquarters: Shinjuku-ku, Tokyo; President: Kazuhiro Hasegawa; hereinafter \"Glocalink\") has issued new shares through a third-party allotment to Japan Tobacco Inc.<\/p>\n

With this transaction, Glocalink will begin investing in and fostering technology startups not only in Japan, but also in other countries.<\/p>\n

\u25a0 Characteristics of Glocalink, Inc.<\/strong><\/p>\n

Up until now, GLOKA LINK's management members have supported the commercialization of various seeds and the investment and nurturing of venture companies, mainly in Japan. GLOCA-LINK is a startup investment and nurturing business that aims to work with founders to overcome the various difficulties faced by seed-stage technology companies, such as raising funds and securing management personnel, and to grow together with them.<\/p>\n

 <\/p>\n

About Glocalink Inc.https:\/\/glocalink.com\/<\/a>)<\/strong><\/p>\n

Location: 5F Iidabashi Miyuki Building, 1-4 Shimomiyaibicho, Shinjuku-ku, Tokyo<\/p>\n

Established: June 2010<\/p>\n

Capital: 9 million yen<\/p>\n

Representative: Kazuhiro Hasegawa, Representative Director<\/p>\n

Business activities: Management consulting business, investment development business<\/p>\n

 <\/p>\n

About Japan Tobacco Inc.http:\/\/www.jti.co.jp\/<\/a>)<\/strong><\/p>\n

Location: 2-2-1 Toranomon, Minato-ku, Tokyo<\/p>\n

Established: April 1985<\/p>\n

Capital: 100 billion yen<\/p>\n

Representative: Mitsuomi Koizumi, President and Representative Director<\/p>\n

Business: In addition to the global tobacco business, pharmaceuticals and processed foods<\/p>\n

Developing business<\/p>","protected":false},"excerpt":{"rendered":"

\u682a\u5f0f\u4f1a\u793e\u30b0\u30ed\u30fc\u30ab\u30ea\u30f3\u30af\uff08\u672c\u793e\uff1a\u6771\u4eac\u90fd\u65b0\u5bbf\u533a\u3001\u4ee3\u8868\u53d6\u7de0\u5f79\uff1a\u9577\u8c37\u5ddd\u3000\u548c\u5b8f\u3001\u4ee5\u4e0b\uff1a\u30b0\u30ed\u30fc\u30ab\u30ea\u30f3\u30af\uff09\u306f\u65e5\u672c\u305f\u3070\u3053\u7523\u696d\u682a\u5f0f\u4f1a\u793e\uff08\u672c\u793e\uff1a\u6771\u4eac\u90fd\u6e2f\u533a\u3001\u4ee3\u8868\u53d6\u7de0\u5f79\u793e\u9577\uff1a\u5c0f\u6cc9 \u5149\u81e3\u3001\u4ee5\u4e0b\uff1aJT\uff09\u3092\u5272\u5f53\u5148\u3068\u3057\u305f\u3001\u7b2c\u4e09\u8005\u5272\u5f53\u5897\u8cc7\u3092\u5b9f\u65bd\u3044\u305f\u3057\u307e […]<\/p>\n","protected":false},"author":54,"featured_media":1426,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[3],"tags":[],"class_list":["post-265","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t